Led U.S. exchanges with 125 IPOs and 30 listing venue switches
7 of the top 10 and 60 percent of the top 100 best performing IPOs in 2013 listed on NASDAQ
More technology and health care companies listed on NASDAQ than any other U.S. exchange in 2013NEW YORK, Dec. 17, 2013 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) welcomed 233* new listings to The NASDAQ Stock Market in 2013, including 125 initial public offerings (IPOs) - more IPOs than any other U.S. exchange, representing a 74 percent increase from the 72* IPOs that occurred on NASDAQ in 2012. 60 percent of the top 100 best performing IPOs overall this year, including seven of the top 10, listed on NASDAQ and combined proceeds raised by NASDAQ-listed IPOs in 2013 totaled more than $15 billion. NASDAQ also led the industry with 30 listing venue switches with $66.6 billion in combined market value switching from our competitors' exchanges to NASDAQ in 2013. "2013 has been a fantastic year for listing activity on NASDAQ as we welcomed more new listings than any other U.S. exchange," said Bruce Aust, Executive Vice President, NASDAQ OMX. "The value of a NASDAQ listing has never been stronger, boosted by our market-leading corporate solutions offerings and unrivaled visibility assets, including the NASDAQ MarketSite in Times Square." Mr. Aust added, "The surge in listing momentum, fueled by a strong market and provisions of the JOBS Act, has brought a diverse mix of industries to our market. We are incredibly proud of the innovators and industry leaders that have joined the NASDAQ family this year and look forward to a strong 2014." The home to innovative technology and health care companies NASDAQ maintained its dominance as the home for technology and health care listings by welcoming 27 technology companies and 50 health care companies in 2013. Technology companies that debuted on NASDAQ this year are currently trading approximately 53 percent above their IPO prices. NASDAQ is home to over 74 percent of technology companies listed on U.S. exchanges. Over 91 percent of health care IPOs this year listed on NASDAQ, including 95 percent of all biotechnology listings. The 36 biotech deals on NASDAQ this year have raised upwards of $2.5 billion.